ClinicalTrials.gg
CompletedNCT06976814NMESUpdated May 16, 2025

Facial Palsy Treatment

An interventional study of Neuro muscular electrical stimulation and Beckmann's oral motor exercises in Facial Palsy and Stroke Rehabilitation, sponsored by Hamad Medical Corporation. Completed at 1 site in Qatar. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-05-16.

Sponsored by Hamad Medical Corporation · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 11 months after the study started (first participant enrolled Apr 2021, registered Apr 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
20 Years to 65 Years
Sex
All
01

Study summary

The Primary objective of the study is to investigate the most effective treatment modalities available to speech language pathologist as well as movement difference by comparing them.

02

Conditions studied

  • Facial Palsy
  • Stroke Rehabilitation

Browse trials for

03

In context

Facial Paralysis

81 studies on the registry are indexed under Facial Paralysis; 28 are open to participants now.

This study's enrollment of 60 is above the median of 50 across 59 interventional studies indexed under Facial Paralysis.

Browse Facial Paralysis studies →

Lead sponsor

Hamad Medical Corporation is the lead sponsor of 139 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with 1st stroke
  • Hemorrhagic stroke
  • Ischemic stroke
  • Right hemispheric stroke
  • Left hemispheric stroke
  • Normal cognitive skills (Based on MOCA)
  • Normal Language (Not Aphasic)
  • Normal swallowing

Exclusion criteria

Exclusion Criteria:

  • Patients with Bell's palsy
  • Facial trauma
  • Post otitis media surgeries
  • Neoplasm, malignant or tumor cell invasion of facial nerve
  • Cognitive impairment
  • Patients with aphasia
  • Patients on defibrillator cardiac devices
  • Patients with pacemakers or any other type of cardiac devices
  • Multiple strokes
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    Neuro muscular electrical stimulation arm

    Other: Neuro muscular electrical stimulation

  • Experimental
    Beckmann Oral Motor Exercise Arm

    Other: Beckmann's oral motor exercises

  • Experimental
    Neuro Muscular Electrical Stimulation Arm + Beckmann Oral Motor Exercise Arm

    Other: Neuro muscular electrical stimulation · Other: Beckmann's oral motor exercises

Interventions

  • OtherNeuro muscular electrical stimulation

    electrical stimulation to facial nerve to improve facial palsy

  • OtherBeckmann's oral motor exercises

    Oral motor exercises to improve facial palsy.

06

What researchers measure

Primary outcomes

  1. Sunnybrook Facial Grading System

    Upon enrollment Sunnybrook is given as baseline. The minimum score a patient may score is 20 out of 100. The higher the score the better (means patient has minor facial asymmetry). Each participant/patient was planned for 30sessions. Baseline score was recorded and beginning of each week Sunnybrook was given and new score was recorded by the same clinician.

    Time frame: Patients were enrolled for 30sessions as per the protocol. Participants were given 5 sessions in a week. Patients were assessed as baseline upon enrollment into the study and re-assessed beginning of each week.

07

Study locations

1 site
  • Hamad Medical Corporation
    Doha, 3050, Qatar
08

References and documents

Individual participant data

Plan to share: No — Patient privacy

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06976814
Responsible party
Mohammed Sajid Hussain (Director of Rehabilitation, Hamad Medical Corporation) — Principal investigator
First posted
May 16, 2025
Start date
Apr 19, 2021
Primary completion
Jun 29, 2022
Completion
Jun 29, 2022
Last update
May 16, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion